Luk, Alvin
The University of Sydney · Children's Hospital of Philadelphia · University of Mississippi · Spark Therapeutics (United States) · University of Pennsylvania
3 papers on CoChat
Most cited papers
- Verified
Identification of a nuclear receptor for bile acids
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science
Drug Transport and Resistance MechanismsCholesterol and Lipid Metabolism
Cited by 2,714
- Verified
Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response
Manno, C. S., Pierce, G. F., Arruda, V. R., Glader, B., Ragni, M., Rasko, J. J. E., Ozelo, M. C., Hoots, K., Blatt, P., Konkle, B., et al. (2006) · Nature Medicine
Virus-based gene therapy researchHemophilia Treatment and Research
Cited by 2,163
- Verified
Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant
George, L. A., Sullivan, S. K., Giermasz, A., Rasko, J. E. J., Samelson-Jones, B. J., Ducore, J., Cuker, A., Sullivan, L. M., Majumdar, S., Teitel, J., et al. (2017) · New England Journal of Medicine
Hemophilia Treatment and ResearchVirus-based gene therapy research
Cited by 762
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free